Fu Shao-Chi, Su Her-Young
Department of Obstetrics and Gynecology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Department of Obstetrics and Gynecology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Taiwan J Obstet Gynecol. 2018 Oct;57(5):753-754. doi: 10.1016/j.tjog.2018.08.027.
Residual ovarian syndrome (ROS) occurs after a hysterectomy in which one or both ovaries have been preserved and cause chronic pelvic pain, an asymptomatic pelvic mass, or dyspareunia. We present a case with classic symptoms and imaging and pathology findings, and review the treatment of residual ovarian syndrome.
A 35-year-old woman with a diagnosis of ROS.
Based on previous literature, almost 50% of patients with ROS require surgery for their symptoms. Treatment of ROS with gonadotropin-releasing hormone analogs or high dose progestogens may be helpful. However, there are limited data supporting the efficacy of pharmacologic therapy. Patients receiving pharmacologic therapy should be counseled about the limited data supporting the efficacy of this approach, the lack of a histologic diagnosis, and the risk of ovarian cancer in residual tissue.
残留卵巢综合征(ROS)发生于保留一侧或双侧卵巢的子宫切除术后,可导致慢性盆腔疼痛、无症状盆腔肿块或性交困难。我们报告一例具有典型症状、影像学及病理学表现的病例,并对残留卵巢综合征的治疗进行综述。
一名诊断为残留卵巢综合征的35岁女性。
根据既往文献,近50%的残留卵巢综合征患者因症状需要手术治疗。使用促性腺激素释放激素类似物或大剂量孕激素治疗残留卵巢综合征可能有效。然而,支持药物治疗疗效的数据有限。对于接受药物治疗的患者,应告知其支持该方法疗效的数据有限、缺乏组织学诊断以及残留组织中存在卵巢癌的风险。